Leadership and Advisors

Jay Pharma has assembled a team of leading oncology experts with backgrounds in cannabinoid research, new drug development, clinical practice, and clinical research, to rapidly advance a pipeline of novel cannabinoid medicines as an adjunct to standard of care cancer treatments.

Allan Oberman

Chairman of the Jay Pharma Board of Directors

Wai Liu, Ph.D.

Research Fellow at St. George’s, University of London

Angus Dalgleish, M.D.

Professor of Oncology at St. George’s University of London

Jerry Zeldis, M.D., Ph.D.

Chief Medical Officer of Sorrento Therapeutics

Michael J. Zelefsky, M.D.

Radiation Oncologist at Memorial Sloan Kettering

James Perry, M.D.

Neuro-Oncologist at Sunnybrook Research Institute

Tali Siegal, M.D.

Professor of Neuro-Oncology at Hebrew University, Jerusalem, Israel

Zvi Vogel, Ph.D.

Neurobiology Chair, Weizmann Institute of Science